The lupus paradox: Natural immunity is protective against disease  by Carroll, Michael C.
Kidney International, Vol. 65 (2004), p. 1540
The lupus paradox: Natural immunity is protective
against disease
MICHAEL C. CARROLL
CBR Institute for Biomedical Research, Inc., and Department of Pediatrics and Department of Pathology, Harvard Medical School,
Boston, Massachusetts
Systemic lupus erythematosus (SLE) is a B-cell–
dependent autoimmune disease that is characterized by
autoantibodies specific for nuclear antigens such as ds-
DNA and histones. Apoptotic blebs released from dy-
ing cells are thought to represent a major source of au-
toantigen. The cellular and molecular basis for SLE is
not known but a major risk factor is deficiency in prod-
ucts of natural immunity. For example, individuals defi-
cient in serum complement proteins C1q or C4 almost
always develop lupus [1]. This presents a paradox as the
complement system is known to mediate pathogenesis
in SLE. In addition to its known role in inflammation,
the complement system participates in humoral antibody
responses via enhancement of B-lymphocyte activation,
germinal center survival and maintenance of long-term
effector responses [2].
Two nonmutually exclusive hypotheses for a protec-
tive role of complement are termed (1) the clearance
hypothesis and (2) B-cell tolerance hypothesis. The for-
mer proposes that complement (and natural immunity)
protects by clearance of apoptotic blebs and sequesters
them from the adaptive immune system [3]. The toler-
ance hypothesis proposes that complement and natural
immunity act in concert to localize lupus antigens to sites
within the primary and secondary lymphoid compart-
ments where developing B cells undergo negative selec-
tion [4]. To examine directly a role for complement C4
in protection from self-reactive B cells we have bred the
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deficient mice with three different immunoglobulin (Ig)
transgeneic models [i.e., conventional Ig heavy and light
chain transgenic (hen lysozyme model); knock-in of a re-
arranged Ig heavy chain termed 56R which is specific for
dsDNA when combined with appropriate Ig light chain
(from Dr. M. Weigert, Princeton); or rearranged Ig heavy
cain and light chain antichromatin specificity termed 564
(from Dr. T. Imanishi-kari, Boston)]. In all three mod-
els, transgeneic B cells undergo extensive negative selec-
tion (i.e. receptor editing, clonal deletion, or anergy), to
neutralize or eliminate escape of self-reactive B cells [5].
Comparison of C4-suffficient or -deficient mice in each
of the three models reveals a loss of negative selection in
the C4-deficient group. Although the precise stage of C4
activity is not clear, these results provide direct evidence
of a protective role for C4 regulation of self-reactive B
cells and support the B-cell tolerance hypothesis.
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